Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.pfizerltd.co.in | |
Market Cap | 17,697.28 Cr. | |
Enterprise Value(EV) | 16,137.04 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 134.07 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 28.85 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.80 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 637.46 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 6.07 | Calculated using Price: 3,868.45 |
Dividend Yield | 0.90 | Period Ending 2022-03 |
No. of Shares Subscribed | 4.57 Cr. | 45,747,732 Shares |
FaceValue | 10 | |
Company Profile | ||
Pfizer is engaged in manufacturing, marketing, trading and export of pharmaceutical products. Pfizer scientists have produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections. The company is taking on some of the world's most difficult diseases, including cancer, arthritis, and osteoporosis. |
1 Day |
|
+0.20% |
1 Week |
|
+1.30% |
1 Month |
|
-10.64% |
3 Month |
|
-13.45% |
6 Month |
|
-7.24% |
1 Year |
|
-14.69% |
2 Year |
|
-13.85% |
5 Year |
|
+70.68% |
10 Year |
|
+240.27% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 18.77 | 5.31 | 14.75 | 14.70 | 14.11 | 15.07 | 15.89 | 17.19 | 23.30 | |
Return on Capital Employed (%) | 28.96 | 15.87 | 22.78 | 22.62 | 21.49 | 23.22 | 20.38 | 23.62 | 29.78 | |
Return on Assets (%) | 14.91 | 4.00 | 11.22 | 10.95 | 10.36 | 11.25 | 12.20 | 13.00 | 17.24 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 658 | 1,973 | 2,164 | 2,419 | 2,683 | 3,011 | 3,395 | 2,393 | 2,864 | 2,916 | |
Non Curr. Liab. | -19 | -35 | 66 | 62 | 52 | 37 | 136 | 85 | 136 | 85 | |
Curr. Liab. | 303 | 609 | 658 | 780 | 954 | 892 | 873 | 774 | 853 | 764 | |
Minority Int. | |||||||||||
Equity & Liab. | 942 | 2,547 | 2,888 | 3,261 | 3,690 | 3,940 | 4,405 | 3,252 | 3,854 | 3,765 | |
Non Curr. Assets | 257 | 1,295 | 1,256 | 1,210 | 1,273 | 1,225 | 1,357 | 1,344 | 1,457 | 1,420 | |
Curr. Assets | 686 | 1,252 | 1,632 | 2,051 | 2,417 | 2,715 | 3,048 | 1,908 | 2,396 | 2,345 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 942 | 2,547 | 2,888 | 3,261 | 3,690 | 3,940 | 4,405 | 3,252 | 3,854 | 3,765 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 1,112 | 1,853 | 2,012 | 1,966 | 1,969 | 2,082 | 2,152 | 2,239 | 2,611 | 2,456 | |
Other Income | 109 | 72 | 87 | 101 | 114 | 167 | 184 | 81 | 63 | 78 | |
Total Income | 1,221 | 1,925 | 2,099 | 2,067 | 2,083 | 2,249 | 2,336 | 2,320 | 2,674 | 2,534 | |
Total Expenditure | -873 | -1,474 | -1,579 | -1,616 | -1,468 | -1,516 | -1,579 | -1,526 | -1,775 | -1,672 | |
PBIDT | 349 | 451 | 520 | 451 | 615 | 733 | 757 | 794 | 899 | 862 | |
Interest | -1 | -2 | -1 | -2 | -1 | -2 | -11 | -15 | -11 | -13 | |
Depreciation | -8 | -131 | -58 | -63 | -66 | -71 | -103 | -109 | -115 | -114 | |
Taxation | -119 | -138 | -165 | -180 | -188 | -231 | -133 | -171 | -160 | -174 | |
Exceptional Items | -111 | 10 | 130 | 53 | |||||||
PAT | 221 | 70 | 305 | 337 | 360 | 429 | 509 | 498 | 613 | 613 | |
Adjusted EPS | 74 | 15 | 67 | 74 | 79 | 94 | 111 | 109 | 134 | 134 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -16 | 132 | 113 | 345 | 329 | 332 | 98 | 323 | 427 | 667 | |
Cash Fr. Inv. | 626 | 103 | -89 | -701 | -250 | -238 | 35 | 1,530 | -469 | -575 | |
Cash Fr. Finan. | -43 | -1,360 | -1 | -62 | -83 | -110 | -110 | -164 | -1,571 | -181 | |
Net Change | 567 | -1,125 | 23 | -417 | -3 | -17 | 23 | 1,690 | -1,613 | -88 | |
Cash & Cash Eqvt | 1,433 | 308 | 488 | 71 | 68 | 51 | 74 | 1,764 | 151 | 63 |
Thu, 02 Feb 2023
Board Meeting Intimation
|
|
Wed, 01 Feb 2023
Board Meeting Intimation
|
|
Fri, 06 Jan 2023
Certificate under SEBI (Depositories and Participants) Regulations, 2018
|
Tue, 07 Feb 2023 |
|
|
|
|
|